|
pubmed:abstractText |
End-stage renal failure is associated with poor outcomes, including increased mortality, after percutaneous coronary intervention (PCI). The effect of milder degrees of renal insufficiency (RI) is less clear, especially with routine stenting and glycoprotein IIb/IIIa inhibitor therapy, which may be of particular benefit in patients with RI.
|
|
pubmed:affiliation |
Interventional Cardiology Program, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
|
